close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BRC Inc. Class A Common Stock (NY:BRCC)

1.260 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about BRC Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
A Glimpse Into The Expert Outlook On BRC Through 4 Analysts
 
Via Benzinga
Black Rifle (BRCC) Q2 Revenue Rises 6.5%
Via The Motley Fool
Earnings Scheduled For August 4, 2025
 
Via Benzinga
An Overview of BRC's Earnings
 
Via Benzinga
What Analysts Are Saying About BRC Stock
 
Via Benzinga
What's going on in today's pre-market session
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
Earnings Scheduled For May 5, 2025
 
Via Benzinga
What Analysts Are Saying About BRC Stock
 
Via Benzinga
Beyond The Numbers: 5 Analysts Discuss BRC Stock
 
Via Benzinga
Expert Outlook: BRC Through The Eyes Of 4 Analysts
 
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
Top 3 Risk Off Stocks You'll Regret Missing This Month
 
Via Benzinga
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Deep Dive Into BRC Stock: Analyst Perspectives (3 Ratings)
 
Via Benzinga
Analyst Expectations For BRC's Future
 
Via Benzinga
Demystifying BRC: Insights From 5 Analyst Reviews
 
Via Benzinga
The Analyst Verdict: BRC In The Eyes Of 6 Experts
 
Via Benzinga
Black Rifle Coffee Stock Slips After-Market On Q4 Revenue Decline: Retail’s Downbeat
Its Q4 net loss narrowed to $6.7 million from net loss of $14 million in the same period last year. 
Via Stocktwits
Black Rifle Coffee Stock In Focus Ahead Of Q4 Earnings: Retail's Downbeat
Sentiment on Stocktwits turned 'bearish' compared to ‘neutral’ a week ago. Message volume remained in the ‘low’ zone. 
Via Stocktwits
Earnings Scheduled For March 3, 2025
 
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
More Than $2M Bet On This Consumer Defensive Stock? Check Out These 3 Penny Stocks Executives Are Aggressively Buying
 
Via Benzinga
Is Starbucks Hot or Not? Why SBUX Stock Is Trending This Morning.
Starbucks faces an existential crisis as a second activist has taken a stake in SBUX stock, demanding it deliver profits now. 
Via InvestorPlace
BRCC Stock Earnings: BRC Beats EPS, Misses Revenue for Q2 2024
BRCC stock results show that BRC beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Starbucks Stock Is Underperforming the S&P 500 in 2024, but These Other 2 Coffee Stocks Are Soaring.
These lesser-known coffee brands are worth a look as their businesses grow. 
Via The Motley Fool
Topics Stocks
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
This Coffee Stock Has Quietly Doubled in Just the Last 8 Months, and It Isn't Dutch Bros or Starbucks
Is Black Rifle Coffee stock a buy now that the business is on a more sustainable path? 
Via The Motley Fool
BRCC Stock Earnings: BRC Beats EPS, Misses Revenue for Q1 2024
BRCC stock results show that BRC beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Perion Network Cuts Sales Outlook, Joins Range Resources And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling by around 10 points on Monday. 
Via Benzinga
Topics Stocks
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today